Priming with DNA vaccine makes avian flu vaccine work better. NIH study also provides proof of concept for universal influenza vaccine
The immune response to an H5N1 avian influenza vaccine was greatly enhanced in healthy adults if they were first primed with a DNA vaccine expressing a gene for a key H5N1 protein, researchers say. Their report describes results from two clinical studies conducted by researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
This page was last updated on Friday, January 21, 2022